Supporting Inhalation Development for Both Drugs and Devices

Liquids & Semisolids

What Makes a Great Liquid Oral Dose CDMO?

Rob Terry

TriRx Pharmaceutical Services

Sustainable Device

Sustainability by Design in Drug Delivery Devices

Pharma's Almanac

High-Concentration

High-Concentration Biologics Are Redefining Subcutaneous Delivery

Pharma's Almanac

LAI Formulation

The Formulation Science Behind Extended Drug Release

Pharma's Almanac

Drug–Device

Designing Formulations Around Devices Rather Than Vice Versa

Pharma's Almanac

Organoids

Data-Centric Organoid Services for Predictive Drug Response and Next-Generation Oncology Research

Seahee Kim, Ph.D.

Samsung Biologics

Outsourcing

Do you expect continued movement away from one-stop-shop outsourcing toward deeper modality-specific expertise?

Pharma's Almanac

DBS

Advancing Deep Brain Stimulation Through Better Targeting and Smarter Devices

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Tech Transfer

Why Successful Scale-Up and Transfer Capabilities Increasingly Determine Outsourcing Success

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

U.S. CDMO Capacity

More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand

Pharma's Almanac